Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and ischaemic stroke.

Keith W Muir1, Pippa Tyrrell, Naveed Sattar

  • 1Division of Medicine and Neurosciences, University of Manchester, Hope Hospital, Salford, UK. k.muir@clinmed.gla.ac.uk

Current Opinion in Neurology
|May 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Successful Recanalization and Functional Outcomes in Minor Ischemic Stroke With Proven Occlusion: A Secondary Analysis of TEMPO-2 Trial.

Stroke·2026
Same author

Clinical application of <sup>1</sup>H MRS in the human brain at 7T.

Frontiers in neuroscience·2026
Same author

Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial.

Neurology·2026
Same author

Treatment-modifying effects of frailty on stroke reperfusion therapy outcomes: a systematic review and meta-analysis.

Age and ageing·2026
Same author

Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial.

Stroke·2026
Same author

Enhanced Detection of Acute Ischemic Stroke With Low-Field MRI.

Stroke (Hoboken, N.J.)·2026
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Inflammation plays a key role in ischemic stroke, influencing risk, injury, and potential treatments. Further research is needed to confirm inflammation as an independent risk factor and the efficacy of anti-inflammatory therapies.

Area of Science:

  • Cardiovascular Science
  • Neuroscience
  • Immunology

Background:

  • Inflammation is a multifaceted factor in ischemic stroke, acting as a risk factor, trigger, and marker.
  • Its role extends to tissue injury response and potential therapeutic targeting.

Purpose of the Study:

  • To review the various roles of inflammation in ischemic stroke.
  • To examine the evidence linking inflammatory markers to stroke risk and outcomes.
  • To assess the potential of anti-inflammatory strategies in stroke treatment.

Main Methods:

  • Review of epidemiological associations of inflammatory markers (e.g., C-reactive protein).
  • Analysis of tissue inflammation in atherosclerotic plaques and its relevance to carotid disease.
  • Evaluation of humoral and cellular inflammatory responses post-stroke.

Related Experiment Videos

  • Assessment of preclinical and clinical data on anti-inflammatory interventions.

    • Main Results:

    • Epidemiological data show associations between inflammatory markers and stroke, though independence from conventional risk factors is debated.
    • Inflammation in atherosclerotic plaque may indicate symptomatic carotid disease.
    • Post-stroke inflammatory responses can exacerbate tissue injury.
    • Preclinical studies show reduced infarct volume with IL-1 blockade, but clinical trials are pending.

    Conclusions:

    • Inflammation is significantly implicated in acute ischemic stroke.
    • The independent role of inflammation as a risk factor requires further clarification.
    • The clinical benefit of anti-inflammatory interventions for stroke prevention or treatment remains to be established.